C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways

Maeda,Yoshihiro; Kawano,Yoshiaki; Wada,Yoshihiro; Yatsuda,Junji; Motoshima,Takanobu; Murakami,Yoji; Kikuchi,Ken; Imamura,Takahisa; Eto,Masatoshi

doi:10.3892/or.2015.3800

C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways

Authors:
- Yoshihiro Maeda
- Yoshiaki Kawano
- Yoshihiro Wada
- Junji Yatsuda
- Takanobu Motoshima
- Yoji Murakami
- Ken Kikuchi
- Takahisa Imamura
- Masatoshi Eto
View Affiliations

Affiliations: Department of Urology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860‑8556, Japan, Medical Quality Management Center, Kumamoto University Hospital, Kumamoto 860-0811, Japan, Department of Molecular Pathology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan
Published online on: February 13, 2015 https://doi.org/10.3892/or.2015.3800
Pages: 1844-1850

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The anaphylatoxin C5a is a chemoattractant for leukocyte migration via the C5a receptor (C5aR). We recently reported that C5aR was aberrantly expressed in a wide variety of human related cancers, while it also promotes cancer cell invasion by C5a stimulation. However, the biological significance of C5aR expression in renal cell carcinoma (RCC) has not yet been clarified. In the present study, we aimed to elucidate the biological role of C5aR in RCC progression. Clinical RCC specimens were analyzed for C5aR expression and its relationship with baseline demographic data and clinicopathological parameters was analyzed. Moreover, renal carcinoma Renca cells stably expressing C5aR were generated and used to assess the effects of C5a-C5aR axis activation on various cellular phenomena in culture. Immunohistochemistry revealed that 96.7% of the metastatic RCCs (mRCCs) showed C5aR expression, whereas only 50.5% of the non-metastatic RCCs expressed C5aR (P<0.001). Although C5a stimulation did not significantly alter anoikis of C5aR‑expressing Renca cells, C5a elicited cell morphological change and scattering of those cells accompanied with dynamic actin rearrangement, which was not observed in the Renca cells harboring the empty vector only. Moreover, C5a triggered ERK and PI3K‑dependent invasion of the C5aR-expressing renal carcinoma cells. These results are consistent with the idea that the C5a-C5aR axis plays a crucial role in renal carcinoma cell invasion, which may be one of the key steps for RCC metastasis. The present study provides proof‑of‑concept that the C5a-C5aR axis may be a useful therapeutic target for preventing RCC progression.

View Figures

View References

1	Zisman A, Pantuck AJ, Wieder J, et al: Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol. 20:4559–4566. 2002. View Article : Google Scholar : PubMed/NCBI
2	Wada Y, Takahashi W, Kawano Y and Eto M: Current status of pharmacotherapy against metastatic renal cell carcinoma in Japan. Int J Urol. 19:284–295. 2012. View Article : Google Scholar : PubMed/NCBI
3	Müller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50–56. 2001. View Article : Google Scholar : PubMed/NCBI
4	Guo RF and Ward PA: Role of C5a in inflammatory responses. Annu Rev Immunol. 23:821–852. 2005. View Article : Google Scholar : PubMed/NCBI
5	Cao Q, McIsaac SM and Stadnyk AW: Human colonic epithelial cells detect and respond to C5a via apically expressed C5aR through the ERK pathway. Am J Physiol Cell Physiol. 302:C1731–C1740. 2012. View Article : Google Scholar : PubMed/NCBI
6	Kwan WH, van der Touw W, Paz-Artal E, Li MO and Heeger PS: Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J Exp Med. 210:257–268. 2013. View Article : Google Scholar : PubMed/NCBI
7	Chiou WF, Tsai HR, Yang LM and Tsai WJ: C5a differentially stimulates the ERK1/2 and p38 MAPK phosphorylation through independent signaling pathways to induced chemotactic migration in RAW264.7 macrophages. Int Immunopharmacol. 4:1329–1341. 2004. View Article : Google Scholar : PubMed/NCBI
8	Tsai HR, Yang LM, Tsai WJ and Chiou WF: Andrographolide acts through inhibition of ERK1/2 and Akt phosphorylation to suppress chemotactic migration. Eur J Pharmacol. 498:45–52. 2004. View Article : Google Scholar : PubMed/NCBI
9	Nitta H, Wada Y, Kawano Y, et al: Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88). Clin Cancer Res. 19:2004–2013. 2013. View Article : Google Scholar : PubMed/NCBI
10	Kawano Y, Diez S, Uysal-Onganer P, Darrington RS, Waxman J and Kypta RM: Secreted frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer. Br J Cancer. 100:1165–1174. 2009. View Article : Google Scholar : PubMed/NCBI
11	Shvarts O, Janzen N, Lam JS, et al: RENCA/carbonic anhydrase-IX: a murine model of a carbonic anhydrase- IX-expressing renal cell carcinoma. Urology. 68:1132–1138. 2006. View Article : Google Scholar : PubMed/NCBI
12	Berezovskaya O, Schimmer AD, Glinskii AB, et al: Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res. 65:2378–2386. 2005. View Article : Google Scholar : PubMed/NCBI
13	Eto M, Kamiryo Y, Takeuchi A, et al: Posttransplant administration of cyclophosphamide and donor lymphocyte infusion induces potent antitumor immunity to solid tumor. Clin Cancer Res. 14:2833–2840. 2008. View Article : Google Scholar : PubMed/NCBI
14	Frisch SM and Screaton RA: Anoikis mechanisms. Curr Opin Cell Biol. 13:555–562. 2001. View Article : Google Scholar : PubMed/NCBI
15	Banks P, Barker MD and Burton DR: Recruitment of actin to the cytoskeletons of human monocyte-like cells activated by complement fragment C5a. Is protein kinase C involved? Biochem J. 252:765–769. 1988.PubMed/NCBI
16	Monk PN and Banks P: Evidence for the involvement of multiple signalling pathways in C5a-induced actin polymerization and nucleation in human monocyte-like cells. J Mol Endocrinol. 6:241–247. 1991. View Article : Google Scholar : PubMed/NCBI
17	Li K, Fazekasova H, Wang N, et al: Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a. Immunobiology. 217:65–73. 2012. View Article : Google Scholar
18	Bosmann M, Patel VR, Russkamp NF, et al: MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway. FASEB J. 25:4222–4232. 2011. View Article : Google Scholar : PubMed/NCBI
19	Don MJ, Liao JF, Lin LY and Chiou WF: Cryptotanshinone inhibits chemotactic migration in macrophages through negative regulation of the PI3K signaling pathway. Br J Pharmacol. 151:638–646. 2007. View Article : Google Scholar : PubMed/NCBI
20	Mendoza MC, Er EE, Zhang W, et al: ERK-MAPK drives lamellipodia protrusion by activating the WAVE2 regulatory complex. Mol Cell. 41:661–671. 2011. View Article : Google Scholar : PubMed/NCBI
21	Posern G, Saffrich R, Ansorge W and Feller SM: Rapid lamellipodia formation in nerve growth factor-stimulated PC12 cells is dependent on Rac and PI3K activity. J Cell Physiol. 183:416–424. 2000. View Article : Google Scholar : PubMed/NCBI
22	Angelotti ML, Ronconi E, Ballerini L, et al: Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells. 30:1714–1725. 2012. View Article : Google Scholar : PubMed/NCBI
23	Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
24	Hall A: Rho GTPases and the actin cytoskeleton. Science. 279:509–514. 1998. View Article : Google Scholar : PubMed/NCBI
25	Li Z, Hannigan M, Mo Z, et al: Directional sensing requires G beta gamma-mediated PAK1 and PIX alpha-dependent activation of Cdc42. Cell. 114:215–227. 2003. View Article : Google Scholar : PubMed/NCBI
26	Campbell L, Nuttall R, Griffiths D and Gumbleton M: Activated extracellular signal-regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma. Cancer. 115:3457–3467. 2009. View Article : Google Scholar : PubMed/NCBI
27	Horiguchi A, Oya M, Uchida A, Marumo K and Murai M: Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma. J Urol. 169:710–713. 2003. View Article : Google Scholar : PubMed/NCBI
28	Figlin RA, Kaufmann I and Brechbiel J: Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: new strategies for overcoming resistance to VEGFR and mTORC1 inhibitors. Int J Cancer. 133:788–796. 2013. View Article : Google Scholar : PubMed/NCBI